Call of the Week: A Bone to Pick

Robert Maltbie |

This week at Singular Research we initiated coverage on Bacterin International Holdings (BONE), a biotech company that we think has a lot of potential for growth. The company, which has a market cap of just over $100 million, develops innovative bone replacement material that is used in surgical procedures. The market that the company operates in is worth about $2 billion in the U.S., and $3.5 billion worldwide.

Bacterin's primary product, OsteoSponge®, has been used in over 100,000 surgeries, so their technology is proven. What makes it different, however, is the fact that the products are made from biologic materials and not synthetics. It's also important to note that Medtronic (MDT), the current market leader in the bone replacement market, is dealing with federal investigations and lawsuits because of allegedly promoting off-label use of its product, which has created serious health issues in patients. So that that could create a tremendous opportunity for Bacterin.

The company currently only serves about 10 percent of hospitals in the U.S. and should grow that as opportunities arise. We expect Bacterin to continue to grow market share as it ramp up its marketing efforts and production capacity. For full year 2011, we expect to see revenues to grow by 100 percent. For 2012, we expect revenues to grow 75 percent and the company should record its first profitable quarter later in the year, and see triple-digit earnings growth in fiscal year 2013.

So as such, Singular's analyst Greg Garner has a target price of $5.75 for Bacterin, which represents considerable upside potential with shares currently trading around $2.80.

Disclosures: To read Singular Research’s important disclosures, click here.

Singular Research

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
DOM Dominion Resources Black Warrior Trust n/a n/a n/a n/a
MDT Medtronic plc. 71.98 0.31 0.43 4,956,518

Comments

Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…